Buy 5 or more, save 35% · code

Back to Catalog

Peptides

Sermorelin 5 mg

$75Per Unit

29-amino acid N-terminal polypeptide fragment containing the fully active sequence of endogenous GHRH. Supplied with comprehensive analytical panel.

Lot SRM2026-11K · COA on request
Lyophilized polypeptide, sterile vial, 5 mg fill
2–8°C

1 × $75.00 = $75.00

4 more units of anything - mix and match - unlocks 35% off with code EHAB35.

Sermorelin 5 mg

$75.00

Research use only
Sermorelin 5 mg research packaging
Lyophilized polypeptide, sterile vial, 5 mg fill
Anubis Research Labs

Documentation

The certificate of analysis for the current lot (Lot SRM2026-11K) is sent on request, so you can review identity and purity testing before you order.

Request the lot COA

Research summary

Sermorelin

Regulatory status
Formerly FDA-approved (Geref) for diagnosing and treating growth-hormone deficiency in children; no longer marketed. FDA determined in 2013 that it was not withdrawn for reasons of safety or effectiveness.
Strongest evidence
Former approved drug with pediatric clinical data
Overview

Sermorelin is the first 29 amino acids of growth-hormone-releasing hormone (GHRH 1-29), the shortest fully active fragment.

What researchers study it for
  • Idiopathic growth-hormone deficiency in children
Mechanism

Stimulates pituitary GHRH receptors to release growth hormone.

Evidence (2)
  1. Review

    Clinical review (BioDrugs 1999)

    Reviews its use in diagnosing and treating children with idiopathic growth-hormone deficiency.[1]

  2. Regulatory

    FDA determination (2013)

    Federal Register notice that Geref was not withdrawn from sale for reasons of safety or effectiveness.[2]

Limitations of the evidence
  • Products on this site are sold for laboratory research only. They are not the medicines used in the trials above, and those results do not apply to research material.
Sources (2)
  1. 1.Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyPrakash A, Goa KL. BioDrugs. 1999 Review
  2. 2.Determination That GEREF (Sermorelin Acetate) Injection ... Was Not Withdrawn From Sale for Reasons of Safety or EffectivenessFederal Register, Mar 4, 2013 Regulatory
Every published studyPubMed search: Sermorelin(opens in a new tab)Every registered trialClinicalTrials.gov search: Sermorelin(opens in a new tab)

Reviewed 2026-10-02. Summaries describe published research and regulatory records; they are not medical advice and do not describe how to use this product. Sold for laboratory research use only.